| Type | Description |
|---|---|
| Definition | acidic nuclear phosphoprotein 32 family member C |
| Date | Results | Publications |
|---|---|---|
| 2015-12-05 10:31:00 | results highlight that certain malignancies with ANP32C/D overexpression or mutation might be specifically targeted using Hsp90 inhibitors. | 26112988 |
| 2014-11-22 13:37:00 | These findings highlight that certain cancers overexpressing pp32r1 or pp32r1 mutants are likely to demonstrate enhanced resistance to FTY720 treatment. | 24335183 |
| 2014-09-27 10:59:00 | pp32r1 binds to HuR to avoid the caspase-mediated decay of HuR in the cytoplasm of cells. | 24398589 |
| 2013-06-22 12:10:00 | CHD4 were significantly upregulated by pp32r1 and pp32r1Y140H overexpression which influence a number of cell cycle regulator genes including p53, p21 and cyclinD1 | 23403278 |
| 2010-01-21 00:00:00 | expression levels vary among human tumor cell lines, with the highest levels found in prostatic adenocarcinoma cell lines | 15146458 |
| Type | IDs |
|---|---|
| Synonymous | PP32R1 |
| Gene |
UniProtKB-ID:
AN32C_HUMAN
UniprotKB:
O43423
UniParc:
UPI000012502B
EMBL:
CH471056,
AC105250,
AF008216
KO:
hsa:23520
|
| Nucleutide sequences |
EMBL-CDS:
EAX04832.1,
AAD12746.1,
AAY40978.1
|
| Protein sequencees |
RefSeq:
NP_001375412.1,
NP_036535.1
|
| Others |
UniRef100:
UniRef100_O43423
UniRef90:
UniRef90_O43423
UniRef50:
UniRef50_O43423
UniGene:
Hs.661161
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员